Urgent call to action: Making gene therapy for Duchenne muscular dystrophy (DMD) affordable and accessible

Br J Clin Pharmacol. 2023 Nov;89(11):3463-3464. doi: 10.1111/bcp.15900. Epub 2023 Sep 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Genetic Therapy
  • Humans
  • Muscular Dystrophy, Duchenne* / genetics
  • Muscular Dystrophy, Duchenne* / therapy